Li Liu Phd, Cfa Email & Phone Number

Alameda, California, US

Alameda, California, US

• Center for Biotechnology (CFB) is a New York State-funded economic development organization that provides technology commercialization services to facilitate new venture creation and support emerging company growth..
• Co-managed $8.7M technology development fund for Long Island Biosciences Hub (LIBH), a consortium of Stony Brook University, Cold Spring Harbor Laboratory, Brookhaven National Laboratory and Feinstein Institute, and.
• Led the solicitation of applications and conducted due diligence on technologies with cross-functional team, resulting $3M investment in promising technologies
• Lead a team to manage the development of 40 technologies and exited five technologies by out-licensing/option deal with strategic partners
• Secured over $10M funding for biotechnology and medical device start-up companies from VCs and angel investors by advising CEOs on strategic planning and due diligence
• Led the identification and screening of biotechnology start-up companies for Life Sciences Summit, an annual early-stage investor and business development conference

• Researched investment opportunities based on scientific review, patent search, market and competitor analysis. Formulated information and prepared reports for general partner regarding investment potential.
• Worked with portfolio company to analyze and evaluate in-licensing and acquisition opportunities, resulting in a partnership with academic institute
• Conducted valuation of biotechnology and medical device companies with multiple financial models

Stony Brook, NY, US

• Supported research proposal writing of first PET imaging project in PI’s group by designing and performing pilot experiments, resulting in the a $500K grant award from NIH
• Initiated and led collaborations involving four professors and five research fellows from Harvard Medical School, Johns Hopkins Medical School, Brookhaven National Laboratory and SUNY at Stony Brook
• Developed original methods to radiolabel front-line TB drugs with more than 90% reduction in reaction time, making it fast enough to conduct subsequent PET imaging before the radiolabel decay
• Led execution of PET imaging of TB drugs inside animals and TB patients to understand their distribution and visualize TB bacteria, providing proof of concept data for diagnostic method development
• Presented research at conferences attended by 100+ scientists three times
• Participated in design and manufacture of home-made PET tracer module by providing chemistry support, reducing cost by 80%

• Company is a university-based facility, providing investigators with data required to drive drug discovery and expedite translational medicine.
• Initiated Drug Metabolism and Pharmacokinetics (DMPK) service and led a team of four people to deliver more than twenty services, generating over $100K revenue
• Worked with clients to design research protocols and to review results, earning high client satisfaction with 50% of returned or referred clients in 2011
• Initiated close collaboration with big pharmaceutical company by on-site visit and routine communication with key personnel in DMPK department, keeping technique up-to-date and competitive

Ph.D., Chemistry

B.S., Chemistry